Teva Pharmaceuticals Deal History & Licensing Activity
Teva Pharmaceuticals is a life sciences. Over the past three years, Teva Pharmaceuticals has been involved in 5 licensing and acquisition transactions, with a primary focus on Small Molecules (5 deals). The company currently has 8 active clinical trials, primarily in Mega Deals.
Deals (12mo)
2
Active Trials
8
Top Modality
Small Molecules
Focus Area
Mega Deals
Teva Pharmaceuticals Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Teva Pharmaceuticals in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Emalex experimental Tourette drug | Emalex Pharmaceuticals | Small Molecules | Phase 3 | acquisition | Apr 2026 |
| Experimental Tourette drug | Emalex Biosciences | Small Molecules | Unknown | acquisition | Apr 2026 |
| TEV-53408 | Royalty Pharma | Antibodies | Phase 2 | license | Jan 2026 |
Teva Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Teva Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Teva Pharmaceuticals Clinical Pipeline
Teva Pharmaceuticals has 8 active clinical trials across 4 development phases.
2
Phase 4
4
Unknown
1
Phase 2
1
Phase 3
See How Your Asset Matches Teva Pharmaceuticals's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Teva Pharmaceuticals Licensing & Deal Activity
Teva Pharmaceuticals is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 5 deals over the past three years, Teva Pharmaceuticals ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Teva Pharmaceuticals include Mega Deals (4 deals and trials), Dermatology (2 deals and trials), Hematological Malignancies (2 deals and trials), and Autoimmune (2 deals and trials). In terms of modality, Teva Pharmaceuticals has shown particular interest in small molecules, antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Teva Pharmaceuticals and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Teva Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.